Adie Friedman, MD
Minimally invasive treatment of thrombosis (clotting) in cancer patients; image-guided biopsies and thermal ablation of tumors; arterial and venous interventions for a variety of cancer types and cancer-related complications.
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, Rutgers New Jersey Medical School, 1992
Diagnostic Radiology Residency at Tufts Medical Center, completed 1997
Interventional Radiology Fellowship at NewYork-Presbyterian/Weill Cornell Medical Center and Memorial Sloan Kettering Cancer Center, completed in 1998
Diagnostic Radiology and Interventional Radiology
I am an interventional radiologist — a physician who uses x-ray, CT scan, ultrasound, and MRI to perform procedures less invasively. These procedures are typically performed under moderate intravenous sedation instead of general anesthesia, allowing for quicker recovery times.
I discovered Interventional Radiology as a Radiology resident when we performed minimally invasive procedures on disabled veterans with arterial blockages in the legs. It was truly gratifying to see the patients the day after the procedure, walking up and down the hall without pain. The fact that the procedure was done through a tiny skin nick, with no incision to heal, was also a big plus. Over the years, I have applied similar techniques to cancer patients using minimally invasive techniques to treat a variety of conditions.
I believe it’s important to consider the entire person when treating cancer patients, weighing the pros and cons of every intervention and providing patient-centered care. Collaboration with our surgical and medical colleagues is critical to get their perspectives and consensus on the best treatment options.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Adie Friedman discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.